カテゴリー： 世界, Grand View Research

脳磁図検査の世界市場2025-2030

【英語タイトル】Magnetoencephalography Market Size, Share & Trends Analysis Report By Application (Clinical, Research), By End Use (Hospitals, Imaging Centers), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2025 - 2030

Grand View Researchが出版した調査資料（GVR709AZ5589）・商品コード：GVR709AZ5589
・発行会社（調査会社）：Grand View Research
・発行日：2025年2月
・ページ数：約180
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Individual License（1名様閲覧用）USD5,950 ⇒換算￥856,800見積依頼/購入/質問フォーム
Team License（5名様閲覧用）USD6,950 ⇒換算￥1,000,800見積依頼/購入/質問フォーム
Enterprise License（閲覧人数無制限）USD8,950 ⇒換算￥1,288,800見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

2024年の世界における脳磁図（MEG）市場の規模は約3億710万米ドルと推定されており、2025年から2030年にかけて年平均成長率（CAGR）5.9%で成長し、2030年には約4億3,260万米ドルに達する見通しです。市場成長の主な要因は、MEGシステムの技術革新とその採用拡大、さらに神経疾患の世界的な増加によるものです。

地域別では、2024年に北米が市場の33.9%を占めて最大シェアを保持しており、特に米国が北米内で最も大きな市場となっています。用途別では、臨床分野が最大シェアを占め、今後も最も高い成長率（6.1%）で拡大すると見込まれています。エンドユーザー別では、病院が36.0%と最大のシェアを占め、診断や手術前の脳機能マッピングへのMEGの利用が進んでいます。

高齢化の進行も市場拡大の大きな要因であり、アルツハイマー病やパーキンソン病などの神経変性疾患の増加がMEG技術への需要を高めています。例えば、2023年には米国で65歳以上の6.7百万人がアルツハイマー型認知症を患っていると報告されています。

MEGスキャナーは、てんかん、脳腫瘍、感情、痛覚などの神経疾患の研究において極めて有効で、神経磁気信号が頭蓋骨を歪まずに通過する特性を活用しています。最近では、ハードウェアやコンピューター処理能力の向上により、MEG装置への関心が再び高まっています。世界で約200台のMEG装置が使用されており、導入数は増加傾向です。

技術革新や研究開発の活発化も市場を押し上げる要因です。たとえば、東京工業大学では高解像度のダイヤモンド量子マグネトメーターが開発され、英国ノッティンガム大学では2歳児の脳活動を測定可能なMEG装置が導入されました。さらに、米国NIHは2023年にUCサンディエゴの研究所に200万ドルを助成し、MEG装置の導入と神経疾患の研究を支援しています。

規制機関であるFDAやEMAは、MEG機器の安全性や有効性に関する基準を設定しており、メーカー各社はこれらの基準に沿って製品開発を進めています。MEG関連企業は、販売拡大のための設置促進に加え、提携・共同研究を通じて市場競争力を高めています。例えば、MEGIN社は2023年にFIND Neuroと提携し、脳ネットワークマッピング技術を活用した神経疾患治療への応用を進めています。

地域別の市場動向では、アジア太平洋地域が高い成長率を示しており、中国、日本、インドなどが急速に医療インフラを整備しつつあります。中国では高齢化に伴う神経疾患の増加、日本では世界有数の高齢化率が市場成長を後押ししています。インドでは政府の医療投資と研究支援が拡大中です。欧州では英国、ドイツ、フランスが主要市場で、技術革新と高水準の医療体制が整っています。ラテンアメリカや中東・アフリカでも、神経疾患の増加や医療技術の導入が進んでいます。

主要企業には、Compumedics Limited、MEGIN、Ricoh、FieldLine Inc.、Cerca Magneticsなどがあり、これらが市場をリードしています。今後も診断精度の向上と技術の進化により、MEG市場はさらなる拡大が期待されます。

The global magnetoencephalography market size was estimated at USD 307.1 million in 2024 and is projected to reach USD 432.6 million by 2030, growing at a CAGR of 5.9% from 2025 to 2030. One of the primary reasons likely to drive market expansion during the forecast period is increasing technological improvements in magnetoencephalography (MEG) systems and their growing adoption, as well as the rising prevalence of neurological disorders causing death and disability worldwide.

Key Market Trends & Insights
• North America dominated the magnetoencephalography market with the largest revenue share of 33.9% in 2024.
• The magnetoencephalography market in the U.S. accounted for the largest market revenue share in North America in 2024.
• Based on application, the clinical segment accounted for the largest revenue share in 2024 and is further expected to grow at the fastest CAGR of 6.1% over the forecast period.
• Based on end use, the hospital segment led the market with the largest revenue share of 36.0% in 2024.

Market Size & Forecast
• 2024 Market Size: USD 307.1 Million
• 2030 Projected Market Size: USD 432.6 Million
• CAGR (2025-2030): 5.9%
• North America: Largest market in 2024

Furthermore, neurodegenerative diseases primarily affect people in their middle to late years of life, and their prevalence is predicted to rise as the population ages. According to the Harvard Neurodiscovery Center, one in every five Americans will be over the age of 65 by 2030. If left untreated, more than 12 million Americans will suffer from neurodegenerative disorders in the next 30 years.

MEG scanners have proved to be one of the most effective devices for investigating epilepsy, brain tumors, emotions, pain perception, and other neurological problems. MEG takes advantage of the fact that neuromagnetic impulses pass through the skull and scalp without being distorted. While technology has been around for decades, recent advances in computer power and hardware have generated growing interest in scanners. There are an estimated 200 MEG scanners in use worldwide, and the number is expanding. For instance, in January 2022, MEGIN announced the sale of its TRIUXTM neo, magnetoencephalography (MEG) system to the Norman Fixel Institute for Neurological Diseases at the University of Florida Health (UF Health).
The increasing geriatric population also significantly contributes to market growth. As people age, they become more susceptible to a range of neurological disorders such as Alzheimer’s disease, Parkinson’s disease, and various forms of dementia. These conditions not only affect the quality of life of the elderly but also pose significant challenges to healthcare systems worldwide. Consequently, there is a rising demand for effective treatments, medications, and therapeutic interventions tailored to manage and alleviate these neurological conditions in older adults. According to the data published by Alzheimer’s Association, in 2023, about 6.7 million Americans aged 65 and above are experiencing Alzheimer’s dementia.

Key Magnetoencephalography Companies:
The following are the leading companies in the magnetoencephalography market. These companies collectively hold the largest market share and dictate industry trends.
• Compumedics Limited
• MEGIN
• Ricoh
• CTF MEG NEURO INNOVATIONS, INC.
• FieldLine Inc.
• Cerca Magnetics Limited

❖ レポートの目次 ❖

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Application
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application outlook
2.2.2. End use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Magnetoencephalography Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increase in prevalence of neurological disorders
3.2.1.2. Technological advancements
3.2.2. Market restraint analysis
3.2.2.1. High cost of MEG
3.2.2.2. Presence of alternative diagnostic devices
3.3. Magnetoencephalography Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Magnetoencephalography Market: Application Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Magnetoencephalography Application Market Movement Analysis
4.3. Global Magnetoencephalography Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
4.4. Clinical
4.4.1. Clinical market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Dementia
4.4.2.1. Dementia diagnosis market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Autism
4.4.3.1. Autism market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.4. Schizophrenia
4.4.4.1. Schizophrenia market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.5. Multiple Sclerosis
4.4.5.1. Multiple sclerosis market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.6. Stroke
4.4.6.1. Stroke market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.7. Epilepsy
4.4.7.1. Epilepsy market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.8. Others
4.4.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Research
4.5.1. Research market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Magnetoencephalography Market: End Use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Magnetoencephalography End Use Market Movement Analysis
5.3. Global Magnetoencephalography Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Hospitals
5.4.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Imaging Centers
5.5.1. Imaging centers market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Academic and Research Institutes
5.6.1. Academic and research institutes market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Magnetoencephalography Market: Regional Estimates & Trend Analysis By Application, End Use
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.5. North America
6.5.1. U.S.
6.5.1.1. Key country dynamics
6.5.1.2. Competitive scenario
6.5.1.3. Regulatory framework/ reimbursement structure
6.5.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.2. Canada
6.5.2.1. Key country dynamics
6.5.2.2. Competitive scenario
6.5.2.3. Regulatory framework/ reimbursement structure
6.5.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.3. Mexico
6.5.3.1. Key country dynamics
6.5.3.2. Competitive scenario
6.5.3.3. Regulatory framework/ reimbursement structure
6.5.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Europe
6.6.1. Regulatory framework/ reimbursement structure
6.6.2. UK
6.6.2.1. Key country dynamics
6.6.2.2. Competitive scenario
6.6.2.3. Regulatory framework/ reimbursement structure
6.6.2.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
6.6.3. Germany
6.6.3.1. Key country dynamics
6.6.3.2. Competitive scenario
6.6.3.3. Regulatory framework/ reimbursement structure
6.6.3.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
6.6.4. France
6.6.4.1. Key country dynamics
6.6.4.2. Competitive scenario
6.6.4.3. Regulatory framework/ reimbursement structure
6.6.4.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
6.6.5. Italy
6.6.5.1. Key country dynamics
6.6.5.2. Competitive scenario
6.6.5.3. Regulatory framework/ reimbursement structure
6.6.5.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
6.6.6. Spain
6.6.6.1. Key country dynamics
6.6.6.2. Competitive scenario
6.6.6.3. Regulatory framework/ reimbursement structure
6.6.6.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
6.6.7. Norway
6.6.7.1. Key country dynamics
6.6.7.2. Competitive scenario
6.6.7.3. Regulatory framework/ reimbursement structure
6.6.7.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
6.6.8. Sweden
6.6.8.1. Key country dynamics
6.6.8.2. Competitive scenario
6.6.8.3. Regulatory framework/ reimbursement structure
6.6.8.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
6.6.9. Denmark
6.6.9.1. Key country dynamics
6.6.9.2. Competitive scenario
6.6.9.3. Regulatory framework/ reimbursement structure
6.6.9.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Regulatory framework/ reimbursement structure
6.7.2. Japan
6.7.2.1. Key country dynamics
6.7.2.2. Competitive scenario
6.7.2.3. Regulatory framework/ reimbursement structure
6.7.2.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
6.7.3. China
6.7.3.1. Key country dynamics
6.7.3.2. Competitive scenario
6.7.3.3. Regulatory framework/ reimbursement structure
6.7.3.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
6.7.4. India
6.7.4.1. Key country dynamics
6.7.4.2. Competitive scenario
6.7.4.3. Regulatory framework/ reimbursement structure
6.7.4.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
6.7.5. Australia
6.7.5.1. Key country dynamics
6.7.5.2. Competitive scenario
6.7.5.3. Regulatory framework/ reimbursement structure
6.7.5.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
6.7.6. South Korea
6.7.6.1. Key country dynamics
6.7.6.2. Competitive scenario
6.7.6.3. Regulatory framework/ reimbursement structure
6.7.6.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
6.7.7. Thailand
6.7.7.1. Key country dynamics
6.7.7.2. Competitive scenario
6.7.7.3. Regulatory framework/ reimbursement structure
6.7.7.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
6.8. Latin America
6.8.1. Regulatory framework/ reimbursement structure
6.8.2. Brazil
6.8.2.1. Key country dynamics
6.8.2.2. Competitive scenario
6.8.2.3. Regulatory framework/ reimbursement structure
6.8.2.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
6.8.3. Argentina
6.8.3.1. Key country dynamics
6.8.3.2. Competitive scenario
6.8.3.3. Regulatory framework/ reimbursement structure
6.8.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
6.9. MEA
6.9.1. Regulatory framework/ reimbursement structure
6.9.2. South Africa
6.9.2.1. Key country dynamics
6.9.2.2. Competitive scenario
6.9.2.3. Regulatory framework/ reimbursement structure
6.9.2.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
6.9.3. Saudi Arabia
6.9.3.1. Key country dynamics
6.9.3.2. Competitive scenario
6.9.3.3. Regulatory framework/ reimbursement structure
6.9.3.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
6.9.4. UAE
6.9.4.1. Key country dynamics
6.9.4.2. Competitive scenario
6.9.4.3. Regulatory framework/ reimbursement structure
6.9.4.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
6.9.5. Kuwait
6.9.5.1. Key country dynamics
6.9.5.2. Competitive scenario
6.9.5.3. Regulatory framework/ reimbursement structure
6.9.5.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Key company market share analysis, 2024
7.4. Company Position Analysis
7.5. Company Categorization (Emerging Players, Innovators and Leaders
7.6. Company Profiles
7.6.1. Compumedics Limited
7.6.1.1. Company overview
7.6.1.2. Financial performance
7.6.1.3. Product benchmarking
7.6.1.4. Strategic initiatives
7.6.2. MEGIN
7.6.2.1. Company overview
7.6.2.2. Financial performance
7.6.2.3. Product benchmarking
7.6.2.4. Strategic initiatives
7.6.3. Ricoh
7.6.3.1. Company overview
7.6.3.2. Financial performance
7.6.3.3. Product benchmarking
7.6.3.4. Strategic initiatives
7.6.4. CTF MEG NEURO INNOVATIONS, INC.
7.6.4.1. Company overview
7.6.4.2. Financial performance
7.6.4.3. Product benchmarking
7.6.4.4. Strategic initiatives
7.6.5. FieldLine Inc.
7.6.5.1. Company overview
7.6.5.2. Financial performance
7.6.5.3. Product benchmarking
7.6.5.4. Strategic initiatives
7.6.6. Cerca Magnetics Limited
7.6.6.1. Company overview
7.6.6.2. Financial performance
7.6.6.3. Product benchmarking
7.6.6.4. Strategic initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 4 Global magnetoencephalography market by End Use, 2018 – 2030 (USD Million)
Table 5 North America magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 6 North America magnetoencephalography market by End Use, 2018 – 2030 (USD Million)
Table 7 North America magnetoencephalography market by Country, 2018 – 2030 (USD Million)
Table 8 U.S. magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 9 U.S. magnetoencephalography market by End Use, 2018 – 2030 (USD Million)
Table 10 Canada magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 11 Canada magnetoencephalography market by End Use, 2018 – 2030 (USD Million)
Table 12 Mexico magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 13 Mexico magnetoencephalography market by End Use, 2018 – 2030 (USD Million)
Table 14 Europe magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 15 Europe magnetoencephalography market by End Use, 2018 – 2030 (USD Million)
Table 16 Europe magnetoencephalography market by Country, 2018 – 2030 (USD Million)
Table 17 UK magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 18 UK magnetoencephalography market by End Use, 2018 – 2030 (USD Million)
Table 19 Germany magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 20 Germany magnetoencephalography market by End Use, 2018 – 2030 (USD Million)
Table 21 France magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 22 France magnetoencephalography market by End Use, 2018 – 2030 (USD Million)
Table 23 Italy magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 24 Italy magnetoencephalography market by End Use, 2018 – 2030 (USD Million)
Table 25 Spain magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 26 Spain magnetoencephalography market by End Use, 2018 – 2030 (USD Million)
Table 27 Denmark magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 28 Denmark magnetoencephalography market by End Use, 2018 – 2030 (USD Million)
Table 29 Sweden magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 30 Sweden magnetoencephalography market by End Use, 2018 – 2030 (USD Million)
Table 31 Norway magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 32 Norway magnetoencephalography market by End Use, 2018 – 2030 (USD Million)
Table 33 Asia Pacific magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 34 Asia Pacific magnetoencephalography market by End Use, 2018 – 2030 (USD Million)
Table 35 Asia Pacific magnetoencephalography market by Country, 2018 – 2030 (USD Million)
Table 36 China magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 37 China magnetoencephalography market by End Use, 2018 – 2030 (USD Million)
Table 38 Japan magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 39 Japan magnetoencephalography market by End Use, 2018 – 2030 (USD Million)
Table 40 India magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 41 India magnetoencephalography market by End Use, 2018 – 2030 (USD Million)
Table 42 Australia magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 43 Australia magnetoencephalography market by End Use, 2018 – 2030 (USD Million)
Table 44 Thailand magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 45 Thailand magnetoencephalography market by End Use, 2018 – 2030 (USD Million)
Table 46 South Korea magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 47 South Korea magnetoencephalography market by End Use, 2018 – 2030 (USD Million)
Table 48 Latin America magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 49 Latin America magnetoencephalography market by End Use, 2018 – 2030 (USD Million)
Table 50 Latin America magnetoencephalography market by Country, 2018 – 2030 (USD Million)
Table 51 Brazil magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 52 Brazil magnetoencephalography market by End Use, 2018 – 2030 (USD Million)
Table 53 Argentina magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 54 Argentina magnetoencephalography market by End Use, 2018 – 2030 (USD Million)
Table 55 Middle East & Africa magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 56 Middle East & Africa magnetoencephalography market by End Use, 2018 – 2030 (USD Million)
Table 57 Middle East & Africa magnetoencephalography market by Country, 2018 – 2030 (USD Million)
Table 58 South Africa magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 59 South Africa magnetoencephalography market by Product, 2018 – 2030 (USD Million)
Table 60 South Africa magnetoencephalography market by End Use, 2018 – 2030 (USD Million)
Table 61 Saudi Arabia magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 62 Saudi Arabia magnetoencephalography market by Product, 2018 – 2030 (USD Million)
Table 63 Saudi Arabia magnetoencephalography market by End Use, 2018 – 2030 (USD Million)
Table 64 UAE magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 65 UAE magnetoencephalography market by Product, 2018 – 2030 (USD Million)
Table 66 UAE magnetoencephalography market by End Use, 2018 – 2030 (USD Million)
Table 67 Kuwait magnetoencephalography market by Application, 2018 – 2030 (USD Million)
Table 68 Kuwait magnetoencephalography market by Product, 2018 – 2030 (USD Million)
Table 69 Kuwait magnetoencephalography market by End Use, 2018 – 2030 (USD Million)



★調査レポート[脳磁図検査の世界市場2025-2030] (コード：GVR709AZ5589)販売に関する免責事項を必ずご確認ください。
★調査レポート[脳磁図検査の世界市場2025-2030]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 細胞＆遺伝子治療CDMO市場-規模、シェア、動向分析レポート、予測2024-2030
  • 日本の医薬品開発製造受託機関（CDMO）市場規模、シェア、動向分析レポート、予測2023-2030
  • Digital Therapeutics Market Size, Share & Trends Analysis Report By Application (Diabetes, Obesity), By End Use (Patients, Providers, Payers, Employers), By Region, And Segment Forecasts, 2024 – 2030
  • 医療機器リサイクルサービスの世界市場2024-2030
  • ビデオ管理システム（VMS）の世界市場2024-2030
  • Global Digital Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
  • アルミダイカストマシンの世界市場2024-2030
  • 標的タンパク質分解市場2020-2030
  • Global Electronic Load Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
  • Global AC Power Supply Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

    • ◆H&Iグローバルリサーチのお客様（例）◆